Optic neuropathy in cancer patients. Report of a case possibly related to 5 fluorouracil toxicity and review of the literature
- PMID: 12635664
- DOI: 10.1023/a:1020613600826
Optic neuropathy in cancer patients. Report of a case possibly related to 5 fluorouracil toxicity and review of the literature
Abstract
We report the case of a 72-year-old woman suffering from bone metastatic breast cancer and treated with continuous intravenous 5 fluorouracil (5FU) chemotherapy, who presented with a bilateral asymmetric anterior optic neuropathy (ON). A deficiency of dihydropyrimidine dehydrogenase (DPD) was documented. Patients with DPD deficiency are at increased risk for developing unusual and/or severe toxicity to 5FU. We discuss the differential diagnosis of anterior ON and we suggest that 5FU can be responsible for optic nerve toxicity in patients with DPD deficiency.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous